Stocktoria

Definium Therapeutics, Inc. DFTX

Nasdaq · stock · Medicinal Chemicals & Botanical Products · website · IPO 2015-05-04

Definium Therapeutics, Inc. statistics & valuation

Market cap$4.9B
P / B14.8×
Return on equity-55.3%
Net cash$217.3M
Enterprise value USD$4.7B
Earnings yield EBIT/EV-3.5%
Return on capital-44.5%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
202020212022202320242025
Operating margin (%)
202020212022202320242025
Return on equity (%)
-44.70% -61.30% -37.60% -122.50% -45.00% -55.30% 202020212022202320242025
Shares outstanding
28.1M 38.0M 41.1M 75.1M 98.8M 202020212022202320242025
Net debt ($)
-$85.6M -$251.9M -$217.3M 202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-41.60% -56.70% -33.40% -76.90% -36.00% -41.80% 202020212022202320242025
Free cash flow margin (%)
202020212022202320242025
Debt / equity (×)
0.18× 0.09× 0.12× 202020212022202320242025
EPS ($)
-$3.40 -$1.84 -$2.44 -$1.54 -$2.06 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Return on assets-41.8%-36.0%-76.9%-33.4%-56.7%-41.6%
Return on equity-55.3%-45.0%-122.5%-37.6%-61.3%-44.7%
Debt / equity0.12×0.09×0.18×———
Current ratio6.297.253.228.1613.1827.10

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.